Fulgent Diagnostics

Fulgent Diagnostics

Fulgent Diagnostics

A pharmaceutical and next generation molecular diagnostics company focusing on developing and commercializing cancer therapeutics and companion diagnostics.
Founded
2011
Raised
$32.6M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$27,160,000
Venture capital - 2016
$5,400,000
Venture capital - 2016
Team Size
1–10
Employees

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Fulgent Diagnostics makes some noise.